Please provide your email address to receive an email when new articles are posted on . On April 4, CMS announced it would not include Medicare Part D coverage of obesity drugs in its rule changes for ...

First blood-only liquid biopsy test for molecular residual disease testing now covered for certain fee-for-service Medicare patients in US with stage II or III colorectal cancer PALO ALTO, ...

Chandra is an emergency physician and global health policy specialist. Hoover is a former federal worker, sociobehavioral researcher, and global health technical specialist. We both lost our jobs as ...

Starting in January, Medicare will test out an artificial intelligence (AI) pilot program to decide whether patients get certain procedures covered or not. The Centers for Medicare & Medicaid Services ...

The Centers for Medicare and Medicaid Services on Friday issued a 2026 Medicare Advantage and Part D final rule that makes changes to authorization decisions. One provision restricts a plan's ability ...

Experts discuss the cost of lipoprotein(a) (Lp[a]) tests and how these costs, along with the National Lipid Association’s (NLA) recommendation and supporting clinical evidence, may influence payer ...

On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ultrasound-based renal denervation for the treatment of uncontrolled hypertension ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Non-invasive prenatal testing, or NIPT, now shapes critical ...

Panelists discuss how integrating real-world evidence into coverage frameworks can enhance decision-making and align payer policies with actual patient outcomes. Panelists discuss how real-world ...